Evidence map›Paper›PMID 41903187›Full record

ArticleBriefings in bioinformatics2026

Confidence scoring for deep learning-predicted antibody-antigen complexes: AntiConf as a precision-driven metric.

Serbülent Ünsal, Benjamin Holland, Inci Sardag, Emel Timucin

Abstract read
In one paragraph

Article in Briefings in bioinformatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Serbülent ÜnsalAntiverse, Antiverse ltd., sbarc/spark, Maindy Road, CF24 4HQ Cardiff, United Kingdom.
Benjamin HollandAntiverse, Antiverse ltd., sbarc/spark, Maindy Road, CF24 4HQ Cardiff, United Kingdom.
Inci SardagDepartment of Molecular Biology and Genetics, Bogazici University, North Campus, 34342 Istanbul, Turkey.
Emel TimucinAntiverse, Antiverse ltd., sbarc/spark, Maindy Road, CF24 4HQ Cardiff, United Kingdom.ORCID 0000-0003-0048-0668

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Accurate determination of antibody-antigen (Ab-Ag) complex structures is critical for therapeutic development. While deep learning-based methods, beginning with AlphaFold2 (AF2), have revolutionized multimer predictions, the optimal strategies for Ab-Ag modeling, and the reliability of their confidence scores remain active areas of research. This study evaluates the performance of AF2, Boltz-1, Boltz-1x, Boltz-2, Chai-1, Protenix, Protenix-1, OpenFold3, and ESMFold, on a curated dataset of 200 Ab-Ag complexes. Among the nine methods tested, Protenix-1 emerged as the top performer, with Chai-1 consistently ranking second across multiple success metrics, closely followed by AF2. We observed diverse effects of recycling iterations, with AF2, Chai-1, and Protenix variants benefiting from increased cycles, unlike Boltz variants. We analyzed various model confidence scores, noting high precision from pDockQ2 and high recall from predicted Template-Modeling (pTM) score. By integrating these two scores, we developed antibody confidence (AntiConf), a novel metric that achieves superior performance for all methods in terms of precision and recall. These strengths make AntiConf a valuable post score for both computational predictions and downstream experimental workflows, reflecting its potential to improve Ab-Ag complex predictions by AF2 and AF3 architectures. Altogether, this study addresses current limitations in deep learning-based Ab-Ag complex prediction, showcasing the potential of AntiConf for future assessment studies, and providing a guideline for improving the accuracy of Ab-Ag complex prediction.

Indexed as

Antigen-Antibody ComplexDeep LearningAlgorithmsComputational BiologyHumansModels, MolecularAntigen-Antibody ComplexAF3-based implementationsAlphafold2antibody–antigen complexesmodel confidence scoresmultimer prediction

Identifiers

PMID41903187
PMCPMC13032827

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.